A cooperative study involving 296 pigs was conducted at two experiment stations and at a commercial research farm to evaluate the efficacy of nosiheptide as a growth promotant for growing-finishing swine. At each station, five or six replicate pens of four or five pigs/pen were fed a fortified, corn-soybean meal basal diet with 0, 5.5, 11 or 22 ppm nosiheptide. Initial and final weights averaged 11 and 92 kg, respectively. Daily gain increased quadratically (623, 664, 669, 678 g/d; P less than .03) and feed/gain decreased quadratically (3.35, 3.24, 3.24, 3.28; P less than .02) with increasing level of nosiheptide. Breakpoint analysis indicated that gain plateaued at 6.8 ppm and feed/gain at 5.5 ppm of nosiheptide. Averaged across all levels of nosiheptide, gain and feed/gain during the growing phase (11 to 52 kg body weight) were improved by 13.1 and 7.6%, respectively, by feeding the antibiotic. For the entire growing-finishing period, gain was improved by 5.3% and feed/gain by 2.9% in pigs fed nosiheptide. Although there were large differences in gain and feed/gain, the responses to dietary treatments were similar among the three stations. The results indicate that nosiheptide is an effective growth-promoting agent for growing-finishing swine.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.2527/jas1984.5951125x | DOI Listing |
Molecules
October 2020
Department of Microbial Chemistry, Graduate School of Pharmaceutical Sciences, Kitasato University, Tokyo 108-8641, Japan.
Among four mycobacteria, , , BCG and () , we established a silkworm infection assay with . When silkworms (fifth-instar larvae, = 5) were infected through the hemolymph with (7.5 × 10 CFU/larva) and bred at 37 °C, they all died around 40 h after injection.
View Article and Find Full Text PDFJ Am Chem Soc
April 2017
The Department of Chemistry, §The Department of Biochemistry and Molecular Biology, and ∥The Howard Hughes Medical Institute, The Pennsylvania State University , University Park, Pennsylvania 16802, United States.
Nosiheptide (NOS) is a highly modified thiopeptide antibiotic that displays formidable in vitro activity against a variety of Gram-positive bacteria. In addition to a central hydroxypyridine ring, NOS contains several other modifications, including multiple thiazole rings, dehydro-amino acids, and a 3,4-dimethylindolic acid (DMIA) moiety. The DMIA moiety is required for NOS efficacy and is synthesized from l-tryptophan in a series of reactions that have not been fully elucidated.
View Article and Find Full Text PDFJ Am Chem Soc
May 2010
Fakultat Chemie, Technische Universität Dortmund, Otto-Hahn-Strasse 6, D-44221 Dortmund, Germany.
Ribosomally produced thiopeptide antibiotics are highly promising lead compounds targeting the GTPase-associated region (GAR) of the bacterial ribosome. A representative panel of GAR mutants suspected to confer resistance against thiopeptide antibiotics was reconstituted in vitro and quantitatively studied with fluorescent probes. It was found that single-site mutations of the ribosomal 23S rRNA binding site region directly affect thiopeptide affinity.
View Article and Find Full Text PDFA cooperative study involving 296 pigs was conducted at two experiment stations and at a commercial research farm to evaluate the efficacy of nosiheptide as a growth promotant for growing-finishing swine. At each station, five or six replicate pens of four or five pigs/pen were fed a fortified, corn-soybean meal basal diet with 0, 5.5, 11 or 22 ppm nosiheptide.
View Article and Find Full Text PDFLasalocid at the concentration of .0075% (68 g/ton) with and without roxarsone 45.4 g/ton was fed in combination with the growth promotants bacitracin methylene disalicylate 200 g/ton, bambermycins 2 g/ton, lincomycin 4 g/ton, nosiheptide 2.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!